AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell ArteritisZacks Investment Research • 04/08/25
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell ArteritisPRNewsWire • 04/08/25
Potatoes, discount chains and drugmakers offer havens in stock-market bloodbathMarket Watch • 04/03/25
Biotech Stocks Dive After Trump Tacks On 20% European Tariff. Why AbbVie, Merck Could Be Exposed.Investors Business Daily • 04/02/25
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocksCNBC • 04/01/25
AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025PRNewsWire • 03/26/25
2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive IncomeThe Motley Fool • 03/26/25